SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kerala Ayurveda - Quaterly Results

18 Jul 2025 Evaluate
A fair growth of 14.09% in the revenue at Rs. 175.66 millions was reported in the June 2025 quarter as compared to Rs. 153.96 millions during year-ago period.The Total Profit for the quarter ended June 2025 of Rs. 20.67 millions grew from Rs.-12.94 millions Operating profit Margin for the quarter ended June 2025 improved to 45.71% as compared to -11.31% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 175.66 153.96 14.09 175.66 153.96 14.09 726.89 680.36 6.84
Other Income 99.99 2.74 3549.27 99.99 2.74 3549.27 51.71 30.07 71.97
PBIDT 45.71 -11.31 -504.16 45.71 -11.31 -504.16 -74.16 68.05 -208.98
Interest 7.70 4.00 92.50 7.70 4.00 92.50 39.16 53.98 -27.45
PBDT 38.01 -15.31 -348.27 38.01 -15.31 -348.27 -113.32 14.07 -905.40
Depreciation 12.26 1.94 531.96 12.26 1.94 531.96 21.51 15.74 36.66
PBT 25.75 -17.25 -249.28 25.75 -17.25 -249.28 -134.83 -1.67 7973.65
TAX 5.08 -4.31 -217.87 5.08 -4.31 -217.87 2.98 -2.20 -235.45
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 20.67 -12.94 -259.74 20.67 -12.94 -259.74 -137.81 0.53 -26101.89
Equity 120.32 120.32 0.00 120.32 120.32 0.00 120.32 120.32 0.00
PBIDTM(%) 22.76 -6.83 -433.26 26.02 -7.35 -454.23 -10.20 10.00 -202.00

Kerala Ayurveda Share Price

246.70 4.45 (1.84%)
17-Apr-2026 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.85
Dr. Reddys Lab 1229.65
Cipla 1237.10
Zydus Lifesciences 944.80
Lupin 2313.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×